CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity

Overview of attention for article published in Molecular Cancer, May 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,649 followers.

We've detected a paper from Molecular Cancer that cites a retracted paper post-retraction. Citing paper: https://t.co/h7RQsa1jXm Retracted paper: https://t.co/1gpkUaTyC8

In a recent study, scientists showed that circMEMO1 could promote the demethylation and expression of TCF21 and could be considered a crucial epigenetic modifier in #HepatoCellularCarcinoma progression. 🔬 https://t.co/UeTl2mapqg https://t.co/H2TK1VOuke

New article: CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity https://t.co/AmJTXkHG18 #livercancer #oncology https://t.co/Mnr4txeB4n

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.